Web Content Management
PRODUCTS
-
Revolutionizing Global mRNA Production: Germfree's Innovative Cleanrooms Drive Manufacturing Success
Cleanroom requirements for mRNA manufacturing encompass stringent particle control, temperature and humidity management, solvent management and robust contamination prevention strategies. Germfree’s advanced cleanroom solutions address these challenges, ensuring seamless equipment integration, process adaptability, and compliance with regulatory standards. Their tailored mobile and modular facilities support the emerging trend for localized vaccine production, empowering biopharmaceutical companies to harness the transformative potential of mRNA technology in a rapidly advancing field, and ultimately contributing to global immunization efforts.
-
Gain expert guidance and connect with a global network of qualified QPPVs and LPPVs, who will ensure compliance with pharmacovigilance regulations and tailor their approach to your product launch strategy.
-
Block Clinical provides a single point of contact for Patients and Sites who support them throughout their journey, from start to finish.
-
By removing barriers, and bringing trials to patients where they live, we can expand the geographical reach of clinical research across the globe allowing more patients to participate. Our patient-centric delivery means we can create convenience and comfort working the schedule of the trial around the schedule of the patient and their family, not the other way around. This approach provides important access to medical care, enhances the inclusivity of clinical trials and advances drug development for all.
-
ClinicReady is the surrogate for outsourced drug development team for preclinical biotechs.
WHITE PAPERS AND CASE STUDIES
-
Advancing Compliance And Digital Strategy To Align With Pharma 4.0
AmplifyBio sought to identify areas of its operation where digitalization could yield ROI in a short amount of time. Gain insight into the out-of-the-box solution that aligned with Pharma 4.0.
-
Enabling Simpler, Quieter, And More Precise Wearables Utilizing Disruptive Pump Technology
Disc pumps enable quieter, smaller, and more precise wearable medical devices, improving patient comfort, measurement accuracy, and system reliability for innovative healthcare solutions.
-
Advancing Cell And Gene Therapy Clinical Development In 2023
Examine considerations on bringing together the CMC and clinical teams early in the development process, promoting transparency and communication with regulators, and increasing patient access and diversity in clinical trials.
-
Applying A Platform Approach To Bispecific Antibody Development
Explore how experts were able to adjust a mAb production and purification platform to be applicable for the rapid development and scale up of a BsAb.
-
The Essential Role Of Adjudication Technology In Clinical Trials
With adjudication, learn how teams can enhance the quality and integrity of their research, paving the way for impactful and reliable outcomes in clinical research.
-
eSource Purpose Is Not Just To Complete The EDC
Central eSource transforms data capture from a passive, back-end chore into an active, real-time quality and compliance engine—delivering benefits that extend beyond faster EDC feeds and reduced SDV.
-
Hillshire Brands Uses Manufacturing Intelligence
Explore solutions utilized by the Jimmy Dean brand, part of the Hillshire Brands portfolio, to address weight variance in one-pound sausage rolls that was driving up product giveaway and lost revenue.
-
Impact Of Glycosylation On The Effector Functions Of Monoclonal Antibodies
In an example using rituximab and its biosimilars, explore the significance of minor differences of glycosylation in antibodies and its impact on their properties and functionality.
-
Fast Data Insights Improve Productivity, Client Centricity
Discover how Medidata's Rave CTMS seamlessly met the comprehensive requirements of Catalyst Clinical Research—an exclusive CRO provider specializing in oncology—during a period of rapid expansion.
-
Pharma Manufacturing: Top 10 Pitfalls To Avoid
Pharmaceutical manufacturers face constant challenges and pitfalls common to the industry, but how can you avoid and overcome them to mitigate risk across the board?
-
A Synergy Of Excellence: Partnership During Unprecedented Times
Learn how a partner with the right experience and capabilities is crucial to support accelerated GMP manufacturing and ensure novel vaccines and therapeutics receive regulatory approval.
-
Integrated Strategies for Achieving Regulatory Milestones Faster
Learn how an innovative formulation platform reduced development timelines and allowed a sponsor to find the optimal nafamostat formulation without adding unnecessary delays.
NEWS
-
Athelas Strengthens Market Leadership In Strategic Partnership With Resilient Healthcare3/7/2025
Athelas, powered by Commure, announced a strategic partnership with Resilient Healthcare Corp, a trailblazer in health-at-home solutions, to launch a groundbreaking pilot program aimed at revolutionizing outpatient care and hospital billing.
-
New Device's Radio Waves Reveal Lead Contamination In Soil1/2/2025
Radio frequency (RF) signals are a cornerstone of modern technology, enabling wireless communication, data transfer and sensing applications across a wide range of fields and tasks.
-
Weill Cornell Medicine Receives Grant For Blood Test To Diagnose Breast Cancer1/3/2024
Weill Cornell Medicine researchers received a $2.4M grant from the U.S. Department of Defense Breast Cancer Research Program to validate a new blood test for the early detection of breast cancer.
-
Applied DNA Receives Approval For TR8(TM) Pharmacogenomic (PGx) Testing Service From New York State Department Of Health6/13/2024
Applied DNA Sciences, Inc. ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that the New York State Department of Health ("NYSDOH") approved the Company's TR8 PGx ("TR8") pharmacogenomic (PGx) testing service.
-
Microbes In Brooklyn Superfund Site Teach Lessons On Fighting Industrial Pollution4/15/2025
NYU Tandon-led research team discovers unprecedented genetic adaptations in Gowanus Canal organisms, revealing a potential new approach for cleaning contaminated waters and recovering valuable resources.